DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis

Background Interplays between Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB) in human and host professional phagocytes, namely macrophages (Mφs) and dendritic cells (DCs), are central to immune protection against TB and to TB pathogenesis. We and others have recently shown that the C-type lectin dendritic cell–specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN; CD209) mediates important interactions between mycobacteria and human monocyte-derived DCs (MoDCs) in vitro. Methods and Findings In order to explore the possible role of DC-SIGN in M. tuberculosis infection in vivo, we have analysed DC-SIGN expression in broncho-alveolar lavage (BAL) cells from patients with TB (n = 40) or with other non-mycobacterial lung pathologies, namely asthma (n = 14) and sarcoidosis (n = 11), as well as from control individuals (n = 9). We show that in patients with TB, up to 70% of alveolar Mφs express DC-SIGN. By contrast, the lectin is barely detected in alveolar Mφs from all other individuals. Flow cytometry, RT-PCR, and enzyme-linked immunosorbent assay analyses of BAL-derived fluids and cells indicated that M. tuberculosis infection induces DC-SIGN expression in alveolar Mφs by a mechanism that is independent of Toll-like receptor-4, interleukin (IL)-4, and IL-13. This mechanism most likely relies on the secretion of soluble host and/or mycobacterial factors that have yet to be identified, as both infected and uninfected bystander Mφs were found to express DC-SIGN in the presence of M. tuberculosis. Immunohistochemical examination of lung biopsy samples from patients with TB showed that the bacilli concentrate in pulmonary regions enriched in DC-SIGN-expressing alveolar Mφs in vivo. Ex vivo binding and inhibition of binding experiments further revealed that DC-SIGN–expressing alveolar Mφs constitute preferential target cells for M. tuberculosis, as compared to their DC-SIGN− counterparts. In contrast with what has been reported previously in MoDCs in vitro, ex vivo DC-SIGN ligation by mycobacterial products failed to induce IL-10 secretion by alveolar Mφs, and IL-10 was not detected in BALs from patients with TB. Conclusion Altogether, our results provide further evidence for an important role of DC-SIGN during TB in humans. DC-SIGN induction in alveolar Mφs may have important consequences on lung colonization by the tubercle bacillus, and on pulmonary inflammatory and immune responses in the infected host.

[1]  G. Hunninghake,et al.  ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. , 1999, The European respiratory journal.

[2]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[3]  C. Figdor,et al.  How C‐type lectins detect pathogens , 2005, Cellular microbiology.

[4]  H. Klech Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. , 1989, The European respiratory journal.

[5]  G. Hunninghake,et al.  ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[6]  O. Schwartz,et al.  DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.

[7]  D. Voelker,et al.  Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. , 1995, Journal of immunology.

[8]  David G. Russell,et al.  Mycobacterium tuberculosis: here today, and here tomorrow , 2001, Nature Reviews Molecular Cell Biology.

[9]  D. Weissman,et al.  Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro , 2002, Journal of leukocyte biology.

[10]  R. Stokes,et al.  Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient. , 1998, Journal of immunology.

[11]  M. Morosini,et al.  The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  O. Schwartz,et al.  Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. , 2005, The Biochemical journal.

[13]  S. Kaufmann,et al.  How can immunology contribute to the control of tuberculosis? , 2001, Nature Reviews Immunology.

[14]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[15]  J. Abastado,et al.  DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. , 2004, Blood.

[16]  H. Klech,et al.  Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group on BAL. , 1990, The European respiratory journal.

[17]  M. Daffé,et al.  Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent , 1997, Infection and immunity.

[18]  T. Geijtenbeek,et al.  Pathogens target DC‐SIGN to influence their fate DC‐SIGN functions as a pathogen receptor with broad specificity , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  J. Ernst,et al.  Macrophage Receptors for Mycobacterium tuberculosis , 1998, Infection and Immunity.

[20]  J. Rodríguez-Fernández,et al.  DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents1 , 2002, The Journal of Immunology.

[21]  T. Graeber,et al.  TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells , 2005, Nature Medicine.

[22]  B M Curtis,et al.  Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Tailleux,et al.  How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis. , 2003, Trends in microbiology.

[24]  H. Yeager,et al.  Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages. , 1992, The Journal of laboratory and clinical medicine.

[25]  V. Boussiotis,et al.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.

[26]  J. Heuser,et al.  Trafficking and Release of Mycobacterial Lipids from Infected Macrophages , 2000, Traffic.

[27]  B. Gicquel,et al.  The Cell Surface Receptor DC-SIGN Discriminates betweenMycobacterium Species through Selective Recognition of the Mannose Caps on Lipoarabinomannan* , 2003, The Journal of Biological Chemistry.

[28]  J. Abastado,et al.  Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells 1 , 2003, The Journal of Immunology.

[29]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[30]  J. Ficker,et al.  Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells1 , 2005, The Journal of Immunology.

[31]  M. Schlaak,et al.  In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases. , 2000, European cytokine network.

[32]  R. Pauwels,et al.  Identification and characterization of human pulmonary dendritic cells. , 2005, American journal of respiratory cell and molecular biology.

[33]  B. Spellberg,et al.  Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  J. Ellner,et al.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.

[35]  G. Hunninghake,et al.  ATS/ERS/WASOG statement on sarcoidosis , 1999 .

[36]  D. Russell,et al.  Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. , 2001, European journal of cell biology.

[37]  R. Kirsch,et al.  Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells , 1996, Infection and immunity.